byInstitut National de la Sante et de la Recherche MedicaleGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI152924Cisplatin is a chemotherapy indic
byInstitut National de la Sante et de la Recherche MedicaleGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI152924Cisplatin is a chemotherapy indic
byLund UniversityHazard ratios (95% confidence interval) of all obesity-related cancers and common cancer forms in 400 111 men according to combinations of metabolic health status and body mass
byLund UniversityHazard ratios (95% confidence interval) of all obesity-related cancers and common cancer forms in 400 111 men according to combinations of metabolic health status and body mass
by Deb Balzer,Mayo ClinicCredit: Mayo ClinicTreatments for breast cancer have improved over the years, but much research still needs to be done.That's why Dr. Saranya Chumsri, a Mayo Clinic
by Deb Balzer,Mayo ClinicCredit: Mayo ClinicTreatments for breast cancer have improved over the years, but much research still needs to be done.That's why Dr. Saranya Chumsri, a Mayo Clinic
by Fred Hutchinson Cancer CenterCredit: CC0 Public DomainA blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detect
by Fred Hutchinson Cancer CenterCredit: CC0 Public DomainA blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detect
by David Bradley,InderscienceCredit: Unsplash/CC0 Public DomainNew research from India has shown how machine learning, colloquially known as artificial intelligence or AI, could improve the earl
by David Bradley,InderscienceCredit: Unsplash/CC0 Public DomainNew research from India has shown how machine learning, colloquially known as artificial intelligence or AI, could improve the earl
by Jess Reid,University of Western AustraliaKiller T cells surround a cancer cell. Credit: NIHA new cancer treatment with the ability to normalise tumour blood vessels and boost the body's i
by Jess Reid,University of Western AustraliaKiller T cells surround a cancer cell. Credit: NIHA new cancer treatment with the ability to normalise tumour blood vessels and boost the body's i
byUniversity of LuxembourgScientists from the University of Luxembourg together with researchers from the Integrated Biobank of Luxembourg (IBBL) and the Luxembourg Institute of Health (LIH) hav
byUniversity of LuxembourgScientists from the University of Luxembourg together with researchers from the Integrated Biobank of Luxembourg (IBBL) and the Luxembourg Institute of Health (LIH) hav
by Noah Brown,Massachusetts General HospitalAnti-VEGF treatment improves the efficacy of EGFRvIII-CAR-T cells in murine GBM tumor models. (A) Schematic representation of experimental setup to ev
by Noah Brown,Massachusetts General HospitalAnti-VEGF treatment improves the efficacy of EGFRvIII-CAR-T cells in murine GBM tumor models. (A) Schematic representation of experimental setup to ev
by University of MichiganCredit: CC0 Public DomainUsing an old anesthesia drug to pull people out of the depths of severe depression has gone from fringe idea to widespread use in just a few year
by University of MichiganCredit: CC0 Public DomainUsing an old anesthesia drug to pull people out of the depths of severe depression has gone from fringe idea to widespread use in just a few year
byLa Trobe UniversityCredit: La Trobe UniversityThe mission was to test the effects of zero gravity on Trichoplax, the tiny animals traveling to more than 250 km above the Earth, whose ancient m
byLa Trobe UniversityCredit: La Trobe UniversityThe mission was to test the effects of zero gravity on Trichoplax, the tiny animals traveling to more than 250 km above the Earth, whose ancient m
byEuropean Society for Medical OncologySome European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs followin
byEuropean Society for Medical OncologySome European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs followin